DEC 04, 2019 12:55 PM PST

Predicting Death with Clinical Immune Indicators

WRITTEN BY: Kara Marker

Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward linking biomarkers of health with specific diseases and therapeutic targets.

Researchers made use of data from the 1999-2010 National Health and Examination Survey (NHANES) - including more than 31,000 participants - to study the ability of immune and inflammatory clinical indicators to predict human health outcomes. Senior author Jarrod Dalton, PhD, described the study as “investigating the predictive power of components of a patient’s white blood cell count.”

White blood cell count is a clinical indicator of health and part of the normal blood work completed during a typical health exam. The study found that low levels of one type of white blood cells, called lymphocytes, is linked with death from heart disease, cancer, and respiratory infections like influenza and pneumonia. The connection between these diseases and low lymphocyte levels, or lymphopenia, held true regardless of age, other blood-based immune markers, and clinical risk factors.

Lymphocytes make up anywhere from 20 to 40 percent of all white blood cells and include B cells, T cells, and natural killer (NK) cells. Important for the immune response to infection, lymphocyte levels can be abnormally low as a result of underproduction, cellular destruction, and spleen or lymph node blockages. Conditions like AIDS are a type of lymphopenia that is acquired rather than genetic.

The link between lymphopenia and mortality grew in cases where patients also presented with other blood abnormalities. This included elevated red blood cell distribution width and C-reactive protein levels, an indicator of inflammation.

Scientists are still working to elucidate the physiological mechanisms linking these biomarkers to specific diseases. After that, scientists can develop targeted therapies.

In the meantime, explains co-author Sadeer Al-Kindi, MD, they can “design systems that allow physicians to use pragmatic immune status indicators to ensure that the 10-20% of the general population at highest risk for mortality do not fall through the cracks of routine preventive care and early detection services."

Sources: Cleveland Clinic, JAMA Network Open, National Heart, Lung, and Blood Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 10, 2021
Health & Medicine
Care Managers During COVID-19, A Vital Value-Add
AUG 10, 2021
Care Managers During COVID-19, A Vital Value-Add
At the beginning of 2020, fear was unleashed globally as the United States government announced a public health emergenc ...
AUG 23, 2021
Microbiology
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
AUG 23, 2021
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
Several viruses are known to cause chronic infections, one is hepatitis C virus (HCV). Researchers studying these infect ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 23, 2021
Immunology
Houses on Mars Held Together With Astronaut Blood?!
SEP 23, 2021
Houses on Mars Held Together With Astronaut Blood?!
A protein abundantly present in the blood plasma of astronauts is perfect for building shelters in outer space, say rese ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
Loading Comments...